PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A trial of the Kampo formula daiobotanpito (containing rhubarb) combined with antibiotics showed no significant difference in treatment success rates compared to placebo, although the treatment group showed a significant reduction in hospitalization days [PMID:40595170].
An ethanolic extract of R. tanguticum inhibited several H1N1 subtypes by blocking viral attachment, penetration, and virus-endosome fusion [PMID:27302738].
Chrysophanein extracted from R. tanguticum ameliorated symptoms and repaired mucosal barrier integrity in mouse models [PMID:40992441].
R. tanguticum is noted to show a significant decrease in neuronal injury via mechanisms such as increasing superoxide dismutase and catalase activities [PMID:31206893].
Evidence summary
PubMed sources
- 1.PMID: 37814999 (2024) — Exploration of plant metabolomics variation and absorption characteristics of water-extracted Rheum tanguticum and ethanol-extracted Rheum tanguticum by UHPLC-Q-TOF-MS/MS. · Phytochemical analysis : PCA
- 2.PMID: 36445877 (2022) — Comparative study of the Rheum tanguticum's chemical contents based on spatial distribution characteristics. · PloS one
- 3.PMID: 41158982 (2025) — Rhubarb: Traditional Uses, Phytochemistry, Multiomics-Based Novel Pharmacological and Toxicological Mechanisms. · Drug design, development and therapy
- 4.PMID: 34629100 (2021) — Advances in the study of emodin: an update on pharmacological properties and mechanistic basis. · Chinese medicine
- 5.PMID: 26357619 (2014)